Milan, April 8 beraking latest news Salute) – “Reiterating that the Vaxzevria vaccine is approved from 18 years of age, based on current evidence, taking into account the low risk of adverse reactions of the thromboembolic type compared to the high mortality from Covid-19 in the age groups more advanced, it is shown that its preferential use is recommended in people over the age of 60 “. This is what is read in the circular with which the Ministry of Health updates the recommendations on the AstraZeneca anti-Covid vaccine.
The document, signed by the general director of Prevention Gianni Rezza, also confirms that, “by virtue of the data available to date, those who have already received a first dose of the Vaxzevria vaccine can complete the vaccination cycle with the same vaccine“.
COPYRIGHT today © breaking latest news